These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 32291831)

  • 1. Nilotinib Fails to Prevent Synucleinopathy and Cell Loss in a Mouse Model of Multiple System Atrophy.
    Lopez-Cuina M; Guerin PA; Canron MH; Delamarre A; Dehay B; Bezard E; Meissner WG; Fernagut PO
    Mov Disord; 2020 Jul; 35(7):1163-1172. PubMed ID: 32291831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nilotinib reverses loss of dopamine neurons and improves motor behavior via autophagic degradation of α-synuclein in Parkinson's disease models.
    Hebron ML; Lonskaya I; Moussa CE
    Hum Mol Genet; 2013 Aug; 22(16):3315-28. PubMed ID: 23666528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. α-Synucleinopathy associated c-Abl activation causes p53-dependent autophagy impairment.
    Karim MR; Liao EE; Kim J; Meints J; Martinez HM; Pletnikova O; Troncoso JC; Lee MK
    Mol Neurodegener; 2020 Apr; 15(1):27. PubMed ID: 32299471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of tyrosine kinase c-Abl contributes to α-synuclein-induced neurodegeneration.
    Brahmachari S; Ge P; Lee SH; Kim D; Karuppagounder SS; Kumar M; Mao X; Shin JH; Lee Y; Pletnikova O; Troncoso JC; Dawson VL; Dawson TM; Ko HS
    J Clin Invest; 2016 Aug; 126(8):2970-88. PubMed ID: 27348587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral-mediated oligodendroglial alpha-synuclein expression models multiple system atrophy.
    Bassil F; Guerin PA; Dutheil N; Li Q; Klugmann M; Meissner WG; Bezard E; Fernagut PO
    Mov Disord; 2017 Aug; 32(8):1230-1239. PubMed ID: 28556404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain injections of glial cytoplasmic inclusions induce a multiple system atrophy-like pathology.
    Teil M; Dovero S; Bourdenx M; Arotcarena ML; Camus S; Porras G; Thiolat ML; Trigo-Damas I; Perier C; Estrada C; Garcia-Carrillo N; Morari M; Meissner WG; Herrero MT; Vila M; Obeso JA; Bezard E; Dehay B
    Brain; 2022 Apr; 145(3):1001-1017. PubMed ID: 35285474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered α-synuclein, parkin, and synphilin isoform levels in multiple system atrophy brains.
    Brudek T; Winge K; Rasmussen NB; Bahl JM; Tanassi J; Agander TK; Hyde TM; Pakkenberg B
    J Neurochem; 2016 Jan; 136(1):172-85. PubMed ID: 26465922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rapidly progressive multiple system atrophy-cerebellar variant model presenting marked glial reactions with inflammation and spreading of α-synuclein oligomers and phosphorylated α-synuclein aggregates.
    Yamaguchi H; Nishimura Y; Matsuse D; Sekiya H; Masaki K; Tanaka T; Saiga T; Harada M; Kira YI; Dickson DW; Fujishima K; Matsuo E; Tanaka KF; Yamasaki R; Isobe N; Kira JI
    Brain Behav Immun; 2024 Oct; 121():122-141. PubMed ID: 38986725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular tweezer CLR01 reduces aggregated, pathologic, and seeding-competent α-synuclein in experimental multiple system atrophy.
    Herrera-Vaquero M; Bouquio D; Kallab M; Biggs K; Nair G; Ochoa J; Heras-Garvin A; Heid C; Hadrovic I; Poewe W; Wenning GK; Klärner FG; Schrader T; Bitan G; Stefanova N
    Biochim Biophys Acta Mol Basis Dis; 2019 Nov; 1865(11):165513. PubMed ID: 31319154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenic Impact of α-Synuclein Phosphorylation and Its Kinases in α-Synucleinopathies.
    Kawahata I; Finkelstein DI; Fukunaga K
    Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive striatonigral degeneration in a transgenic mouse model of multiple system atrophy: translational implications for interventional therapies.
    Refolo V; Bez F; Polissidis A; Kuzdas-Wood D; Sturm E; Kamaratou M; Poewe W; Stefanis L; Angela Cenci M; Romero-Ramos M; Wenning GK; Stefanova N
    Acta Neuropathol Commun; 2018 Jan; 6(1):2. PubMed ID: 29298733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The c-Abl inhibitor, Radotinib HCl, is neuroprotective in a preclinical Parkinson's disease mouse model.
    Lee S; Kim S; Park YJ; Yun SP; Kwon SH; Kim D; Kim DY; Shin JS; Cho DJ; Lee GY; Ju HS; Yun HJ; Park JH; Kim WR; Jung EA; Lee S; Ko HS
    Hum Mol Genet; 2018 Jul; 27(13):2344-2356. PubMed ID: 29897434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propagation of pathological α-synuclein in marmoset brain.
    Shimozawa A; Ono M; Takahara D; Tarutani A; Imura S; Masuda-Suzukake M; Higuchi M; Yanai K; Hisanaga SI; Hasegawa M
    Acta Neuropathol Commun; 2017 Feb; 5(1):12. PubMed ID: 28148299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of autophagic protein DEF8 in Lewy bodies.
    Tanaka MT; Miki Y; Bettencourt C; Ozaki T; Tanji K; Mori F; Kakita A; Wakabayashi K
    Biochem Biophys Res Commun; 2022 Oct; 623():170-175. PubMed ID: 35921708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous oligodendroglial alpha-synuclein and TPPP/p25α orchestrate alpha-synuclein pathology in experimental multiple system atrophy models.
    Mavroeidi P; Arvanitaki F; Karakitsou AK; Vetsi M; Kloukina I; Zweckstetter M; Giller K; Becker S; Sorrentino ZA; Giasson BI; Jensen PH; Stefanis L; Xilouri M
    Acta Neuropathol; 2019 Sep; 138(3):415-441. PubMed ID: 31011860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing C-terminal truncation mitigates synucleinopathy and neurodegeneration in a transgenic model of multiple system atrophy.
    Bassil F; Fernagut PO; Bezard E; Pruvost A; Leste-Lasserre T; Hoang QQ; Ringe D; Petsko GA; Meissner WG
    Proc Natl Acad Sci U S A; 2016 Aug; 113(34):9593-8. PubMed ID: 27482103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson's disease.
    Price DL; Koike MA; Khan A; Wrasidlo W; Rockenstein E; Masliah E; Bonhaus D
    Sci Rep; 2018 Nov; 8(1):16165. PubMed ID: 30385782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of hemisphere-dependent effects of unilateral intrastriatal injection of α-synuclein pre-formed fibrils on mitochondrial protein levels, dynamics, and function.
    Creed RB; Memon AA; Komaragiri SP; Barodia SK; Goldberg MS
    Acta Neuropathol Commun; 2022 May; 10(1):78. PubMed ID: 35606853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATH434 Reduces α-Synuclein-Related Neurodegeneration in a Murine Model of Multiple System Atrophy.
    Heras-Garvin A; Refolo V; Schmidt C; Malfertheiner K; Wenning GK; Bradbury M; Stamler D; Stefanova N
    Mov Disord; 2021 Nov; 36(11):2605-2614. PubMed ID: 34236731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism.
    Prusiner SB; Woerman AL; Mordes DA; Watts JC; Rampersaud R; Berry DB; Patel S; Oehler A; Lowe JK; Kravitz SN; Geschwind DH; Glidden DV; Halliday GM; Middleton LT; Gentleman SM; Grinberg LT; Giles K
    Proc Natl Acad Sci U S A; 2015 Sep; 112(38):E5308-17. PubMed ID: 26324905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.